Drugs / ginkgolide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03772847 | Jul 2018 → May 2020 | — | Second Affiliated Hospital, School of Medicine, Zhejiang University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ginkgolide | “Ginkgolide® treatment on neurological function” PMID 34925044 ↗ Dec 2021 |
| Known as | Ginkgolide injection | “The main components of Ginkgolide injection (Ginkgo) are ginkgolide, ginkgolides A, ginkgolides B and ginkgolides C.” NCT03772847 ↗ |
| Action | Inhibit | “Ginkgo biloba lactone can antagonize PAF” NCT03772847 ↗ |
| Route | Intravenous | “intervention of intravenous Ginkgolide® or control group” PMID 34925044 ↗ Dec 2021 |